GoKawiilNobel laureate David Baker launches AI BioDesign to engineer never-before-seen proteins
David Baker, who shared the 2024 Nobel Prize in Chemistry for computational protein design, is leading a new initiative called AI BioDesign, backed by the Allen Institute, University of Washington and Fred Hutchinson Cancer Center. The project pairs AI models with large-scale lab experiments to design molecules and biological functions that don't exist in nature but are chemically feasible, aiming to build public databases and tools for future medicines and technologies.
GoKawiil's interpretation of the reporting above, not reported fact.
Rather than mimicking evolution's existing solutions, this approach searches an unexplored space of biologically possible molecules, potentially unlocking treatments for cancer, neurodegenerative disease, or plastic-degrading enzymes far faster than nature could evolve them. Because it ventures into truly novel biology, the work also raises new safety and ethical questions about creating substances with no natural precedent.
- AI BioDesign combines AI modeling with lab testing to invent non-natural but chemically viable molecules.
- Nobel laureate David Baker serves as chief scientific officer, backed by three major research institutions.
- Goals include new cancer and neurodegenerative drugs plus enzymes that break down ocean plastics.
Source: wired.com — Jorge Garay, 2026-09-18
Published there as: “He Won the Nobel Prize for Protein Design. Now He Uses AI to Create Molecules Not Found in Nature”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.